Researchers have developed a new class of synthetic antibiotics called macrolones that target both protein production and DNA structure in bacteria, making it exceedingly difficult for bacteria to develop resistance. Their research shows that by disrupting two cellular targets simultaneously, macrolones could significantly impede the evolution of drug-resistant bacteria. ============================================================== A groundbreaking study from the University of Illinois Chicago unveils macrolones, a new type of antibiotic that targets bacteria in two ways, drastically reducing the potential for resistance and marking a significant step forward in infectious disease treatment. A newly discovered antibiotic, which targets two different cellular mechanisms, could make...